Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “modified”

433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 433
Index total 30,257
Page 14 / 19

Quick answer

This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

433 results for “modified” · 30,257 patents in full index Clear search

  1. US 8563269

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  2. US 8551964

    Hsp90 inhibitors with modified toxicity

    The Regents of the University of Colorado · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted

  3. US 8541646

    Genetically modified mice and engraftment

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

  4. US 8519103

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  5. US 8513390

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  6. US 8513005

    DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence

    The United States of America as represented by the Secretary of the Army · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  7. US 8507661

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  8. US 8415457

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  9. US 8415458

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  10. US 8399025

    Polyamine modified particles

    The Board of Regents of the University of Texas System · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  11. US 8394387

    Recombinant modified Bacillus anthracis protective antigen for use in vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  12. US 8383388

    Modified coagulation factor IX polypeptides and use thereof for treatment

    Catalyst Biosciences, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  13. US 8349308

    Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  14. US 8344125

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  15. US 8211464

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  16. US 8173664

    Modified pyrimidine glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted May 8, 2012 · Expires May 3, 2032

    granted

  17. US 8168754

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted May 1, 2012 · Expires Apr 26, 2032

    granted

  18. US 8158754

    Multiple modified derivatives of gelatin and crosslinked material thereof

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  19. US 8106006

    Modified defensins and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted

  20. US 8106160

    N-terminal modified interferon-alpha

    PHARMAESSENTIA CORPORATION · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted

  21. US 8101382

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  22. US 8088379

    Modified T cell receptors and related materials and methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  23. US 8071107

    Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  24. US 8067431

    Chemically modified small molecules

    Nektar Therapeutics · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.